To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Report: Suitors found for Sequoia and Actis' Paras
Morgan Stanley has reportedly found five potential trade buyers for the firms' 70% stake in Paras Pharmaceuticals, which is valued at $700m.
